Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.
Honeyborne I, McHugh TD, Kuittinen I, Cichonska A, Evangelopoulos D, Ronacher K, van Helden PD, Gillespie SH, Fernandez-Reyes D, Walzl G, Rousu J, Butcher PD, Waddell SJ.
Honeyborne I, et al. Among authors: rousu j.
BMC Med. 2016 Apr 7;14:68. doi: 10.1186/s12916-016-0609-3.
BMC Med. 2016.
PMID: 27055815
Free PMC article.